Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 7/20 | 0.70 |
| ▸ | CA1 | P00915 | 4/20 | 0.70 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.49 |
| ▸ | ATM | Q13315 | 2/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | XBP1 | P17861 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.41 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.41 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17617127 | 1.00 | CA2 (0.70) | CA2CA1MAPK1CPB2ATM | |
| SCHEMBL332831 | 1.00 | CA2 (0.70) | CA2CA1MAPK1CPB2ATM | |
| SCHEMBL29167382 | 0.98 | CA2 (0.68) | CA2CA1MAPK1CPB2ATM | |
| SCHEMBL28570078 | 0.98 | CA2 (0.68) | CA2CA1MAPK1CPB2ATM | |
| SCHEMBL15880449 | 0.98 | CA2 (0.68) | CA2CA1MAPK1CPB2ATM | |
| SCHEMBL27676334 | 0.98 | CA2 (0.68) | CA2CA1MAPK1CPB2ATM | |
| Bicarbonate SCHEMBL28407433 | 0.96 | CA2 (0.66) | CA2CA1MAPK1CPB2ATM | |
| Hydrochloric Acid SCHEMBL6340583 | 0.96 | CA2 (0.66) | CA2CA1MAPK1CPB2ATM | |
| SCHEMBL3682929 | 0.94 | CA2 (0.62) | CA2CA1MAPK1CPB2SLC1A2 | |
| SCHEMBL12860221 | 0.94 | CA2 (0.62) | CA2CA1MAPK1CPB2SLC1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160083341-A1 | METHOD FOR PRODUCING a-SUBSTITUTED CYSTEINE OR SALT THEREOF OR SYNTHETIC INTERMEDIATE OF a-SUBSTITUTED CYSTEINE | API CORPORATION (JP) | 2016-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160083341-A1 | METHOD FOR PRODUCING a-SUBSTITUTED CYSTEINE OR SALT THEREOF OR SYNTHETIC INTERMEDIATE OF a-SUBSTITUTED CYSTEINE | MGMT, GSTA1, CBS | CA2 929/4885CA1 683/4885MAPK1 1591/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.